Stocktoria
Alaunos Therapeutics, Inc. TCRT
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2004-08-20
Alaunos Therapeutics, Inc. statistics & valuation
Market cap$5.1M
P / B2.4×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | -84500.0% | -48120.0% | -685340.0% | -1201.4% | -19484.7% |
| Net margin | -83520.0% | -46790.0% | -93580.0% | -1291.2% | -19786.7% |
| FCF margin | -59340.0% | -49710.0% | -606780.0% | -1007.8% | -16279.1% |
| Return on assets | -140.8% | -169.8% | -56.6% | -58.1% | -83.0% |
| Return on equity | -194.0% | -226.8% | -74.2% | -97.9% | -135.6% |
| Debt / equity | — | 0.00× | 0.00× | 0.00× | 0.28× |
| Current ratio | 2.45 | 3.98 | 4.22 | 2.23 | 4.91 |
| Revenue growth | -50.0% | 100.0% | -99.8% | 634.2% | — |
Source: SEC EDGAR filings · CIK 0001107421 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.